SAFETY OF A NEW SEDDS FORMULATION OF ORAL TESTOSTERONE UNDECANOATE (TU) IN HYPOGONADAL MEN: DATA FROM TWO PHASE 3 TRIALS WITH DIFFERENT DOSE-TITRATION ALGORITHMS

被引：0
|
作者：
Swerdloff, R. S. [1 ]
Sulameh, W. [2 ]
Dohs, A.
Faulknel, S. [2 ]
Dudley, R. [2 ]
Flippo, G. [3 ]
Kaminetsky, J. [4 ]
Armory, J. [5 ]
Honig, S. H. [6 ]
Danoff, T. [2 ]
Wang, C. [1 ]
机构：
[1] Univ Calif Los Angeles, Los Angeles, CA 90024 USA
[2] Clarus Therapeut, Northbrook, IL USA
[3] Alabama Clin Theraput, Birmingham, AL USA
[4] Univ Urrol Assoc, New York, NY USA
[5] Univ Washington, Seattle, WA 98195 USA
[6] Yale Univ, New Haven, CT 06520 USA
来源：
JOURNAL OF SEXUAL MEDICINE | 2015年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
136
引用
收藏
页码：150 / 150
页数：1
相关论文
共 19 条
  • [1] Safety of a New SEDDS Formulation of Oral Testosterone Undecanoate (TU) in Hypogonadal Men: Data from Two Phase 3 Trials with Different Dose-Titration Algorithms
    Swerdloff, Ronald S.
    Salameh, Wael A.
    Dobs, Adrian S.
    Faulkner, Sandra M.
    Dudley, Robert E.
    Flippo, Gregory M.
    Kaminetsky, Jed C.
    Amory, John K.
    Danoff, Theodore M.
    Wang, Christina
    ENDOCRINE REVIEWS, 2014, 35 (03)
  • [2] Pharmacokinetics and Efficacy of a New SEDDS Formulation of Oral Testosterone Undecanoate (TU) in Hypogonadal Men: Data from Two Phase 3 Trials with Different Dose-Titration Algorithms
    Swerdloff, Ronald S.
    Salameh, Wael A.
    Dobs, Adrian S.
    Longstreth, James A.
    Faulkner, Sandra M.
    Dudley, Robert E.
    Flippo, Gregory M.
    Amory, John K.
    Kaminetsky, Jed C.
    Danoff, Theodore M.
    Wang, Christina
    ENDOCRINE REVIEWS, 2014, 35 (03)
  • [3] PHARMACOKINETICS AND EFFICACY OF A NEW SEDDS FORMULATION OF ORAL TESTOSTERONE UNDECANOATE (TU) IN HYPOGONADAL MEN: DATA FROM TWO PHASE 3 TRIALS WITH DIFFERENT DOSE-TITIRATION ALGORITHMS
    Swerdloff, R. S.
    Salameh, W.
    Dobs, A.
    Longstreth, J.
    Faulkner, S.
    Dudley, R.
    Flippo, G.
    Kaminetsky, J.
    Amory, J.
    Danoff, T.
    Honig, S. H.
    Wang, C.
    JOURNAL OF SEXUAL MEDICINE, 2015, 12 : 112 - 113
  • [4] TWO-YEAR ADMINISTRATION DATA OF AN ORAL TESTOSTERONE UNDECANOATE (TU) FORMULATION IN HYPOGONADAL MEN
    Swerdloff, R.
    Honig, S.
    Wang, C.
    Gittelman, M.
    Seo, B. W.
    Rohowsky, N.
    Dudley, R.
    JOURNAL OF SEXUAL MEDICINE, 2022, 19 (05): : S128 - S128
  • [5] TWO-YEAR ADMINISTRATION DATA OF AN ORAL TESTOSTERONE UNDECANOATE (TU) FORMULATION IN HYPOGONADAL MEN
    Swerdloff, R.
    Honig, S.
    Wang, C.
    Gittelman, M.
    Sea, B. W.
    Rohowsky, N.
    Dudley, R.
    JOURNAL OF SEXUAL MEDICINE, 2022, 19 (04): : S2 - S2
  • [6] SAFETY ANALYSIS OF AN ORAL TESTOSTERONE UNDECANOATE (TU) FORMULATION FOLLOWING 2 YEARS OF ADMINISTRATION IN HYPOGONADAL MEN
    Swerdloff, Ronald
    Kavoussi, Parviz
    Gittelman, Marc
    Wang, Christina
    Seo, B. Woun
    Rohowsky, Nestor
    Dudley, Robert
    JOURNAL OF UROLOGY, 2021, 206 : E369 - E370
  • [7] Two-Year Analysis of a New Oral Testosterone Undecanoate (TU) Formulation in Hypogonadal Men: Efficacy, Impact on Psychosexual Function, and Safety
    Honig, Stanton
    Gittelman, Marc
    Kaminetsky, Jed
    Wang, Christina
    Amory, John K.
    Rohowsky, Nestor
    Dudley, Robert E.
    Seo, B. Woun
    Newmark, Jay
    Swerdloff, Ronald
    JOURNAL OF SEXUAL MEDICINE, 2022, 19 (12): : 1750 - 1758
  • [8] Effect of Dietary Fat on the Testosterone (T) Pharmacokinetics (PK) of a New Oral Testosterone Undecanoate (TU) Formulation in Hypogonadal Men.
    Yin, A.
    Alfadhli, E.
    Htun, M.
    Dudley, R. E.
    Faulkner, S.
    Hull, L.
    Leung, A.
    Bross, R.
    Swerdloff, R.
    Wang, C.
    ENDOCRINE REVIEWS, 2010, 31 (03)
  • [9] DOSE TITRATION AND SAFETY OF ORAL TESTOSTERONE IN HYPOGONADAL MEN: RESULTS FROM THE SOAR STUDY
    Khera, M.
    Dobs, A. S.
    Wang, C.
    Kaminetsky, J. C.
    Goldstein, I
    Delconte, A.
    Chidambaram, N.
    Patel, M., V
    Nachaegari, S.
    Miner, M. M.
    JOURNAL OF SEXUAL MEDICINE, 2016, 13 (05): : S15 - S15
  • [10] Metabolic Syndrome Parameters in Hypogonadal Men on Long-Term Treatment with Testosterone Undecanoate (TU) Injections Improve Independently from Age: Observational Data from Two Registry Studies
    Yassin, Aksam A.
    Haider, Ahmad
    Doros, Gheorghe
    Traish, Abdulmaged M.
    Saad, Farid
    ENDOCRINE REVIEWS, 2014, 35 (03)
12